Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.
Press releases published on May 28, 2025

Male Infertility Market Projected to Reach 6.62 Billion by 2033 | DataM Intelligence
Male infertility market size reached US$ 4.33 Bn in 2024 and is expected to reach US$ 6.62 Bn by 2033, growing at a CAGR of 4.9% during 2025-2033. NEW YORK, NY, UNITED STATES, May 29, 2025 /EINPresswire.com/ -- The global male infertility market is …

Genetic Testing Market to Witness Robust Growth at a CAGR of 23.1% by 2033 | DataM Intelligence
Genetic Testing Market- Innovative technologies, shifting patient preferences, and supportive government policies fuel market expansion across key regions CALIFORNIA, CA, UNITED STATES, May 29, 2025 /EINPresswire.com/ -- The global genetic testing …

GCRC's Mike Robinson Joins Organizing Committee for Dubai's Global Breast Cancer Treatment Conference
Robinson is known around the world for his nonstop education on the Endocannabinoid System (ECS), and his willingness to help educate the Healthcare Industry SANTA BARBARA, CA, UNITED STATES, May 28, 2025 /EINPresswire.com/ -- Mike Robinson, Founder of …

Global Renin-Angiotensin-System RAS-Acting Agents Market Outlook 2025-2034: Growth Drivers, Share, And Trends
The Business Research Company’s Renin-Angiotensin-System RAS-Acting Agents Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- What Is The Projected Market …

Cyclosporine Global Market Report 2025: Sweeping Across the Globe with Heightened Demand and Market Growth
The Business Research Company's Cyclosporine Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report Explores …

Personalized Medicine Biomarkers Market Report 2025: Size, Trends, and Growth Insights for Global Expansion
The Business Research Company’s Personalized Medicine Biomarkers Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- The Business Research Company’s …

Rhinovirus Infections Drug Market Report 2025: Size, Trends, and Growth Insights for Global Expansion
The Business Research Company's Rhinovirus Infections Drug Market Report 2025: Size, Trends, and Growth Insights for Global Expansion LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest …

Global CTLA4 Inhibitors Market Forecast: Key Growth Drivers, Trends, and Opportunities from 2025 to 2034
The Business Research Company's CTLA4 Inhibitors Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- The Business Research Company’s Latest Report …

Key Trend Shaping The Radiation Oncology Market In 2025: Advanced Radiation Therapy Systems Enhancing Patient Outcomes
The Business Research Company’s Radiation Oncology Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- What Is The Forecasted Growth Of The Radiation Oncology …

Personalized Or Customized Skin Care Global Market Report 2025
The Business Research Company’s Personalized Or Customized Skin Care Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 LONDON, GREATER LONDON, UNITED KINGDOM, May 28, 2025 /EINPresswire.com/ -- The Business Research Company’ …

ATMOS Global Launches QuantumPrinciple Executive Advisors: a Pioneering Executive Search Firm for CEOs & Board Directors
ATMOS Global™ 's "QuantumPrinciple Executive Advisors™ " delivers innovative, data-driven solutions for board and CEO recruitment in a changing world. MELBOURNE, VICTORIA, AUSTRALIA, May 28, 2025 /EINPresswire.com/ -- ATMOS Global Pty Ltd (ATMOS Global …

Nxera Pharma Notes Neurocrine Biosciences Presents New Positive Data from Phase 2 Study of NBI-1117568 in Adults with Schizophrenia at American Society of Clinical Psychopharmacology 2025
Tokyo, Japan and Cambridge, UK, 29 May 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) notes that Neurocrine Biosciences, Inc. announced that it had presented new positive data from the Phase 2 study of NBI-1117568 in adults with …

CORRECTION: Streamex and BioSig Appoint Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer (CIO)
Los Angeles, CA and Vancouver, BC, May 28, 2025 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) ("BioSig") and Streamex Exchange Corporation ("Streamex"), collectively referred to as the combined company, today announced the appointment of …

Rakovina Announces Debentureholder Election to Receive Shares in Partial Satisfaction of Debenture Interest Payment Obligations
VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”) announces that in accordance with the terms of an indenture entered into between the Company and Odyssey Trust …

DMARC MSP Case Study: PowerDMARC Enables ImpactQuill to Launch White-Labeled DMARC Platform
DE, UNITED STATES, May 28, 2025 /EINPresswire.com/ -- PowerDMARC, a global leader in email authentication and domain security solutions, has empowered marketing and SEO consultancy ImpactQuill to launch IQDMARC — a fully white-labeled DMARC monitoring …

SOMAÍ Launches New HCP Portals and AI Assistant as Part of Global Website Enhancements
SOMAÍ has announced the launch of dedicated HCP portals in Australia, Germany, and the United Kingdom, as well as the rollout of a new AI-powered assistant LISBON, PORTUGAL, May 28, 2025 /EINPresswire.com/ -- SOMAÍ, a leading EU-GMP-certified vertically …

Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution
• KHINDIVI is the first and only FDA-approved hydrocortisone oral solution • Commercial launch expected the week of June 2nd • Eton expects combined peak sales of KHINDIVI and ALKINDI SPRINKLE® (hydrocortisone) oral granules to exceed $50 million DEER PARK …

IMUNON Closes Up To $9.75 Million Private Placement Priced At-The-Market Under Nasdaq Rules
$3.25 million upfront with up to an additional $6.5 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants LAWRENCEVILLE, N.J., May 28, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company …

Nyxoah to Present at the Jefferies Global Healthcare Conference
Nyxoah to Present at the Jefferies Global Healthcare Conference Mont-Saint-Guibert, Belgium – May 28, 2025, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops …

Gentherm Announces Participation in Upcoming Second Quarter 2025 Investor Conferences
NOVI, Mich., May 28, 2025 (GLOBE NEWSWIRE) -- Gentherm (NASDAQ:THRM), a global market leader of innovative thermal management and pneumatic comfort technologies, today announced that it is scheduled to participate in the following upcoming investor events …